Tris Pharma, Inc.

United States of America


 
Total IP 78
Total IP Rank # 17,311
IP Activity Score 2.4/5.0    31
IP Activity Rank # 25,030
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

38 15
4 3
14 0
4
 
Last Patent 2025 - Low sodium oxybate once nightly ...
First Patent 1999 - Pharmaceutical composition compr...
Last Trademark 2025 - ADNEURIS THERAPEUTICS
First Trademark 2000 - TRIS PHARMA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Distributorship of pain relief medications; distributorship of pharmaceutical medicines and prepa...
2024 Invention Low sodium oxybate once nightly composition. Compositions providing a once-a-night dose of oxyba...
Invention Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pu...
G/S PHARMACEUTICAL PREPARATIONS WHICH ACT ON THE CENTRAL NERVOUS SYSTEM, INCLUDING MODIFIED RELEASE A...
G/S Pharmaceutical preparations which act on the central nervous system, including modified release a...
G/S Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmac...
Invention Extended release amphetamine tablets. An oral amphetamine extended release solid dose is describ...
G/S Pharmaceutical or medical preparations in liquid dosage form, including, drug delivery systems co...
Invention Methods for improving driving behavior. Use of an oral amphetamine extended release solid dose f...
Invention Low sodium oxybate once nightly composition. Compositions providing a once-a-night dose of oxybat...
2023 Invention Extended release amphetamine compositions. An oral amphetamine extended release liquid suspensio...
2022 Invention Oxybate polyethylene glycol prodrugs. Oxybate-PEG ester prodrugs are provided herein in which the...
Invention Oxybate - cyclodextrin products and conjugates. Oxybate cyclodextrin mono-esters, di-esters, and ...
2021 G/S Pharmaceutical preparations.
Invention Modified release formulations containing drug-ion exchange resin complexes. An aqueous liquid su...
2020 Invention Modified release formulations containing drug-ion exchange resin complexes. A particulate, modif...
G/S Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inh...
2019 G/S Pharmaceutical preparations, namely modified release and extended release stimulants containing a...
G/S Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, i...
2018 Invention Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming sy...
Invention Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system...
Invention Modified release drug powder composition comprising gastro-retentive raft forming systems having ...
Invention Novel clonidine formulation. An oral clonidine dosage unit providing a twenty-four hour extended...
2017 Invention Benzonatate modified release solid tablets and capsules. A modified release benzonatate solid ta...
Invention Methylphenidate extended release chewable tablet. An oral methylphenidate extended release table...
Invention Methylphenidate extended release chewable tablet. An oral methylphenidate extended release tablet...
2016 Invention Orally effective methylphenidate extended release powder and aqueous suspension product. An oral...
Invention Modified release formulations containing drug - ion exchange resin complexes. A particulate, pH-...
Invention Modified release formulations containing drug - ion exchange resin complexes. A particulate, pH-i...
Invention Modified release formulations containing drug-ion exchange resin complexes. A particulate, pH-ind...
Invention Benzonatate modified release solid tablets and capsules. A 12-hour anti-tussive modified release ...
Invention Modified release formulations containing drug-ion exchange resin complexes. A particulate, barrie...
Invention Methylphenidate extended release chewable tablet. An oral dexmethylphenidate extended release ta...
2015 Invention Modified release formulations containing drug-ion exchange resin complexes. A tablet comprising a...
G/S Pharmaceutical preparations for treating coughs, colds, allergies and respiratory diseases, and s...
G/S Oral modified release, extended release, and/or sustained release pharmaceutical preparations for...
2014 Invention Orally effective methylphenidate extended release powder and aqueous suspension product. An oral ...
Invention Modified release formulations containing drug—ion exchange resin complexes. An aqueous liquid sus...
Invention Modified release formulations containing drug-ion exchange resin complexes. An aqueous liquid sus...
2013 Invention Novel clonidine formulation. An oral clonidine dosage unit providing a twenty-four hour extended ...
G/S Pharmaceutical preparations for treating coughs, colds, allergies, and respiratory diseases, and ...
2008 G/S Pharmaceutical or medical preparations in liquid dosage form, namely, drug delivery systems compr...
2004 G/S Scientific research program for the development of preparations or products in liquid form that d...
2000 G/S Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products ...